Atrial fibrillation and atrial flutter in athletes

British Journal of Sports Medicine

Volumn 46, Issue SUPPL. 1, 2012, Pages

  Calvo, Naiara ^a   Brugada, Josep ^b   Sitges, Marta ^b   Mont, Lluís ^b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT;

ABLATION THERAPY; ANIMAL; ATHLETE; AUTONOMIC NERVOUS SYSTEM; CARDIOMYOPATHY; ENDURANCE; EXERCISE; EXERCISE INDUCED CARDIOMEGALY; FIBROSIS; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART ATRIUM FUNCTION; HISTOLOGY; HUMAN; MALE; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; REVIEW; SPORT;

ABLATION TECHNIQUES; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; ATHLETES; ATRIAL FIBRILLATION; ATRIAL FLUTTER; ATRIAL FUNCTION; AUTONOMIC NERVOUS SYSTEM; CARDIOMEGALY, EXERCISE-INDUCED; CARDIOMYOPATHIES; EXERCISE; FIBROSIS; HEART ATRIA; HUMANS; MALE; PHYSICAL ENDURANCE; RATS; SPORTS;

EID: 84869015648     PISSN: 03063674     EISSN: 14730480     Source Type: Journal    
DOI: 10.1136/bjsports-2012-091171     Document Type: Article

References (62)

1. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-5. (Pubitemid 32424106)
2. Furberg CD, Psaty BM, Manolio TA, et al. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994;74:236-41. (Pubitemid 24239044)
3. Benjamin EJ, Wolf PA, DAgostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946-52. (Pubitemid 28446646)
4. Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation-Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 2006;48:854-906. (Pubitemid 44175743)
5. Planas F, Romero-Menor C, Gabriel Vázquez-Oliva JS, et al, on behalf of the FAP Study researchers. Perfil clínico de la fibrilación auricular paroxística primaria (registro FAP). Rev Esp Cardiol 2001;54:838-44.
6. Lévy S, Maarek M, Coumel P et al. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. Circulation 1999;99:3028-35. (Pubitemid 29270433)
7. Morris JN, Everitt MG, Pollard R, et al. Vigorous exercise in leisure-time: protection against coronary heart disease. Lancet 1980;2:1207-10. (Pubitemid 11250853)
8. Kujala UM, Kaprio J, Taimela S, et al. Prevalence of diabetes, hypertension, and ischemic heart disease in former elite athletes. Metabolism 1994;43:1255-60. (Pubitemid 24307939)
9. Karjalainen J, Kujala UM, Kaprio J, et al. Lone atrial fibrillation in vigorously exercising middle aged men: case-control study. BMJ 1998;316:1784-5. (Pubitemid 28269153)
10. Mont L, Sambola A, Brugada J, et al. Long lasting sport practice and atrial fibrillation. Eur Heart J 2002;23:477-82. (Pubitemid 35204187)
11. Hoogsteen J, Schep G, van Hemel NM, et al. Paroxysmal atrial fibrillation in male endurance athletes. A 9-year follow up. Europace 2004;6:222-8. (Pubitemid 38950168)
12. Elosua R, Arquer A, Mont L, et al. Sport practice and the risk of lone atrial fibrillation: a case-control study. Int J Cardiol 2005;108:332-7.
13. Baldesberger S, Bauersfeld U, Candinas R, et al. Sinus node disease and arrhythmias in the long term follow-up of former professional cyclists. Eur Heart J 2008;29:71-8.
14. Heidbuchel H, Anne W, Willems R, et al. Endurance sport is a risk factor for atrial fibrillation after ablation for atrial flutter. Int J Cardiol 2006;107:67-72. (Pubitemid 41767520)
15. Molina L, Mont L, Marrugat J, et al. Long-term endurance sport practice increases the incidence of lone atrial fibrillation in men: a follow-up study. Europace 2008;10:618-23. (Pubitemid 351775294)
16. Mont L, Tamborero D, Elosua R, et al. on behalf of the GIRAFA (Grup Integrat de Recerca en Fibril-lacio Auricular) Investigators. Physical activity, height and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals. Europace 2008;10:15-20. (Pubitemid 351767264)
17. Abdulla J, Nielsen Jr. Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis. Europace 2009;11:1156-9.
18. Aizer A, Gaziano JM, Cook NR, et al. Relation of vigorous exercise to risk of atrial fibrillation. Am J Cardiol 2009;103:1572-7e7.
19. Grimsmo J, Grundvold I, Maehlum S, et al. High prevalence of atrial fibrillation in long-term endurance cross-country skiers: echocardiographic findings and possible predictors-a 28-30 years follow-up study. Eur J Cardiovasc Prev Rehabil 2010;17:100-5.
20. Winhelm M, Roten L, Tanner H, et al. Atrial remodeling, autonomic tone, and lifetime training hours in nonelite athletes. Am J Cardiol 2011;108:580-5.
21. Pelliccia A, Maron BJ, Di Paolo FM, et al. Prevalence and clinical significance of left atrial remodeling in competitive athletes. J Am Coll Cardiol 2005;46:690-6. (Pubitemid 41132699)
22. Mozaffarian D, Furberg CD, Psaty BM, et al. Physical activity and incidence of atrial fibrillation in older adults. The Cardiovascular Health Study. Circulation 2008;118:800-7.
23. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-66. (Pubitemid 28402090)
24. Bjornstad H, Storstein L, Meen HD, et al. Ambulatory electrocardiographic findings in top athletes, athletic students and control subjects. Cardiology 1994;84:42-50. (Pubitemid 24032317)
25. Bettomi M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation 2002;105:2753-9. (Pubitemid 34615147)
26. Amar D, Zhang H, Miodownik S, et al. Competing autonomic mechanisms precede the onset of postoperative atrial fibrillation. JACC 2003;42:1262-70.
27. Ogawa M, Zhou S, Tan AY et al. Left stellate ganglion and vagal nerve activity and cardiac arrhythmias in ambulatory dogs with pacing-induced congestive heart failure. J Am Coll Cardiol 2007;50:335-43. (Pubitemid 47058888)
28. Patterson E, Po SS, Scherlag BJ, et al. Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation. Heart Rhythm 2005;2:632-3.
29. Coumel P. Paroxysmal atrial fibrillation: a disorder of autonomic tone? Eur Heart J 1994;15:9-16. (Pubitemid 24158556)
30. Frustaci A, Chimenti C, Bellocci F, et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997;96:1180-4. (Pubitemid 27344221)
31. Benito B, Gay-Jordi G, Serrano A, et al. Cardiac arrhythmogenic remodeling in a rat model of long-term intensive exercise training. Circulation 2011;123:13-22.
32. Lindsay MM, Dunn FG. Biochemical evidence of myocardial fibrosis in veteran endurance athletes. Br J Sports Med 2007;41:447e52.
33. Breuckmann F, Möhlenkamp S, Nassenstein K, et al. Myocardial late gadolinium enhancement: prevalence, pattern, and prognostic relevance in Marathon runners. Radiology 2009;251:50-7.
34. Wilson M, O'Hanlon R, Prasad S, et al. Diverse patterns of myocardial fibrosis in lifelong, veteran endurance athletes. J Appl Physiol 2011;110:1622-6.
35. Neumayr G, Pfister R, Mitterbauer G, et al. Effect of the "Race Across The Alps" in elite cyclists on plasma cardiac troponins I and T. Am J Cardiol 2002;89:484-6. (Pubitemid 34142533)
36. Rifai N, Douglas PS, O'Toole M, et al. Cardiac troponin Tand I, echocardiographic [correction of electrocardiographic] wall motion analyses, and ejection fractions in athletes participating in the Hawaii Ironman Triathlon. Am J Cardiol 1999;83:1085-9. (Pubitemid 29162796)
37. Scharhag J, Herrmann M, Urhausen A, et al. Independent elevations of Nterminal pro-brain natriuretic peptide and cardiac troponins in endurance athletes after prolonged strenuous exercise. Am Heart J 2005;150:1128-34. (Pubitemid 41773512)
38. Shave R, Whyte G, George D, et al. Prolonged exercise should be considered alongside typical symptoms of acute myocardial infarction when evaluating increases in cardiac troponin T. Heart 2005;91:1219-20. (Pubitemid 41192409)
39. Shave R, Dawson E, Whyte G, et al. Cardiac troponin T in female athletes during a two-day mountain marathon. Scott Med J 2003;48:41-2. (Pubitemid 36582480)
40. Shave R, Dawson E, Whyte G, et al. Evidence of exercise induced cardiac dysfunction and elevated cTnT in separate cohorts competing in an ultra-endurance mountain marathon race. Int J Sports Med 2002;23:489-94. (Pubitemid 35398632)
41. Shave R, George K, Atkinson G, et al. Exercise-induced cardiac troponin T release: a meta-analysis. Med Sci Sports Exerc 2007;39:2099-106. (Pubitemid 350211502)
42. Smith LL. Cytokine hypothesis of overtraining: a physiological adaptation to excessive stress? Med Sci Sports Exerc 2000;32:317-31. (Pubitemid 30108110)
43. Korantzopoulos P, Kolettis T Siogas K, et al. Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress. Med Sci Monit 2003;9:RA225-9. (Pubitemid 37303894)
44. Aviles R, Martin D, Apperson-Hansen C, et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003;108:3006-10. (Pubitemid 37553570)
45. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias. Circulation 2001;104:2886-91.
46. Psychari S, Apostolou T Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol 2005;95:764-7. (Pubitemid 40340139)
47. D'Andrea A, Riegler L, Cocchia R, et al. Left atrial volume index in highly trained athletes. Am Heart J 2010;159:1155-61.
48. Furlanello F, Bertoldi A, Dallago M, et al. Atrial fibrillation in elite athletes. J Cardiovasc Electrophysiol 1998;9:S63-8.
49. Heidbuchel H, Panhuyzen-Goedkoop N, Corrado D, et al. Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions Part I: Supraventricular arrhythmias and pacemakers. Eur J Cardiovasc Prev Rehabil 2006;13:475-84. (Pubitemid 44164254)
50. Zipes D, Ackerman MJ, Estes M, et al. Eligibility recommendations for competitive athletes with cardiovascular abnormalities-General considerations. Task Force 7: arrhythmia. J Am Coll Cardiol 2005;45:1354-63.
51. Kawabata M, Hirao K, Horikawa T, et al. Syncope in patients with atrial flutter during treatment with class Ic antiarrhythmic drugs. J Electrocardiol 2001;34:65-72. (Pubitemid 32210315)
52. Brembilla-Perrot B, Houriez P, Beurrier D, et al. Predictors of atrial flutter with 1:1 conduction in patients treated with class I antiarrhythmic drugs for atrial tachyarrhythmias. Int J Cardiol 2001;80:7-15. (Pubitemid 32800798)
53. Nabar A, Rodriguez LM, Timmermans C, et al. Effect of right atrial isthmus ablation on the occurrence of atrial fibrillation: observations in four patient groups having type I atrial flutter with or without associated atrial fibrillation. Circulation 1999;99:1441-5. (Pubitemid 29140909)
54. Reithmann C, Dorwarth U, Dugas M, et al. Risk factors for recurrence of atrial fibrillation in patients undergoing hybrid therapy for antiarrhythmic drug-induced atrial flutter. Eur Heart J 2003;24:1264-72. (Pubitemid 36840834)
55. Cappato R, Calkins H, Chen SA, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010;3:32-8.
56. Furlanello F, Lupo P, Pittalis M, et al. Radiofrequency catheter ablation of atrial fibrillation in athletes referred for disabling symptoms preventing usual training schedule and sport competition. J Cardiovasc Electrophysiol 2008;19:457-62. (Pubitemid 351634364)
57. Calvo N, Mont L, Tamborero D, et al. Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes. Europace 2010;12:30-6.
58. Koopman P, Nuyens D, Garweg C, et al. Efficacy of radiofrequency catheter ablation in athletes with atrial fibrillation. Europace 2011;13:1386-93.
59. Hsieh MH, Tai CT, Chiang CE, et al. Recurrent atrial flutter and atrial fibrillation after catheter ablation of the cavotricuspid isthmus: a very long-term follow-up of 333 patients. J Interv Card Electrophysiol 2002;7:225-31.
60. Reithmann C, Dorwarth U, Dugas M, et al. Risk factors for recurrence of atrial fibrillation in patients undergoing hybrid therapy for antiarrhythmic drug-induced atrial flutter. Eur Heart J 2003;24:1264-72. (Pubitemid 36840834)
61. Schmieder S, Ndrepepa G, Dong J, et al. Acute and long-term results of radiofrequency ablation of common atrial flutter and the influence of the right atrial isthmus ablation on the occurrence of atrial fibrillation. Eur Heart J 2003;24:956-62. (Pubitemid 36559989)
62. Reynolds MW, Fahrbach K, Hauch O, et al. Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis. Chest 2004;126:1938-45. (Pubitemid 39644002)